The influence of wire localisation for non-palpable breast lesions on visualisation of the sentinel node

Jansen, Jurgen; Bekker, J. H.; Haas, Marie J. de; Verberne, G. H. M.; Budel, Leo M.; Quekel, Lorentz G.B.A.; Klerk, John M. H. de

doi:10.1007/s00259-006-0119-1

Cited by 10 publications

(7 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Wire migration and displacement and interference with the SN procedure are well known [4,6,29]. Unlike the wire guided procedures, there are no serious complications described so far in the ROLL procedure apart from misplacement of the radiotracer which occurred in 1 patient (2.4%) in the present study where no tumor was found on histopathology.…”

Section: Discussioncontrasting

confidence: 66%

Radio guided occult lesion localization (ROLL) for non‐palpable invasive breast cancer

Esser

Hobbelink

Ploeg

et al. 2008

Journal of Surgical Oncology

View full text Add to dashboard Cite

show abstract

Section: Discussioncontrasting

confidence: 66%

Radio guided occult lesion localization (ROLL) for non‐palpable invasive breast cancer

Esser

Hobbelink

Ploeg

et al. 2008

Journal of Surgical Oncology

View full text Add to dashboard Cite

show abstract

“…In both protocols patients had a guide wire in place during injection of the radiotracer. It has been suggested that the presence of a guide wire can disturb the regular draining pattern and radiotracer can leak past the guide wire [ 2 ]. The numbers of guide wires in place during injection of radiotracer were comparable between the two groups.…”

Section: Discussionmentioning

confidence: 99%

“…Therefore a guide wire is usually placed preoperatively in order to localize the tumour. It is suggested that a guide wire placed intra- or peritumorally could disturb the lymph drainage pattern and thereby decrease the success rate of the SLNB [ 2 ].…”

Section: Introductionmentioning

confidence: 99%

Comparison of a 1-day and a 2-day protocol for lymphatic mapping and sentinel lymph node biopsy in patients with nonpalpable breast cancer

Esser

Hobbelink

Isselt

et al. 2009

Eur J Nucl Med Mol Imaging

View full text Add to dashboard Cite

Purpose To compare the identification rate of the sentinel node in a 1-day protocol versus a 2-day protocol in patients with a nonpalpable breast carcinoma. Methods In the 1-day protocol an average dose of 120 MBq 99m Tc-nanocolloid was injected intratumorally on the day of surgery, and in the 2-day protocol an average dose of 370 MBq 99m Tc-nanocolloid was injected intratumorally the day before surgery. Both a gamma ray detection probe and patent blue were used to locate the sentinel node. Results In 57 of 67 patients (85%) treated in the 1-day protocol and in 51 of 56 patients (91%) treated in the 2-day protocol the sentinel node was detected (p=0.311). Of the patients in the 1-day protocol and the 2-day protocol, respectively, 18 (27%) and 13 (23%) showed metastasis (p=0.975) Conclusion There was no significant difference in the identification rate of the sentinel node between the 1-day protocol and the 2-day protocol in patients diagnosed with a nonpalpable breast carcinoma.

show abstract

“…Although two different studies reported in univariate analyses a signi cant correlation between tumor size > 20 mm and SLN nonvisualization lymphoscintigraphy in breast cancer patients, Hellingman et al showed in a multivariable model an equal correlation between tumor size and SLN nonvisualization(6,7,13). Despite this fact, we and the vast majority of other research groups were unable to nd any signi cant effect of tumor size on SLN nonvisualization(2)(3)(4)(5)(14)(15)(16)(17)(18)(19).…”

mentioning

confidence: 56%

Anatomical Breast Imaging Derived Parameters Do Not Provide Incremental Information In Prediction of Nonvisualization of Sentinel Lymph Nodes On Lymphoscintigraphy

Chahid

Verberne

Poel

et al. 2022

Preprint

View full text Add to dashboard Cite

Background: Accurate sentinel lymph node (SLN) staging is essential for both prognosis and treatment in patients with breast cancer. However, the preoperative lymphoscintigraphy may fail to visualize the SLN. The aim of this retrospective study was to investigate whether parameters derived from anatomical breast imaging can predict SLN nonvisualization on lymphoscintigraphy. For this single-center retrospective study all data of mammography, breast magnetic resonance imaging (MRI), and lymphoscintigraphy of SLN procedures from January 2016 to April 2021 were collected and reviewed from the Amsterdam UMC electronic health records database.Results: A total of 758 breast cancer patients were included in this study. The SLN nonvisualization rate was 29.7% on lymphoscintigraphy. Multivariable analysis showed that age ≥ 70 years (P = 0.019; OR: 1.82; 95% CI: 1.10–3.01), BMI ≥ 30 kg/m2 (P = 0.031; OR: 1.59; 95% CI: 1.04–2.43), and nonpalpable tumors (P = 0.034; OR: 1.54; 95% CI: 1.03–2.04) were independent predictors of SLN nonvisualization. Differences in tumor size, Breast Imaging-Reporting and Data System (BI-RADS) classification, or breast density were not significantly associated with SLN nonvisualization.Conclusions: This study shows that, by using a multivariable analysis, risk factors for SLN nonvisualization in breast cancer patients during preoperative lymphoscintigraphy are age ≥70 years, BMI ≥30 kg/m2, and nonpalpable tumors. Parameters derived from mammography or breast MRI, however, are not useful to predict SLN nonvisualization on lymphoscintigraphy.

show abstract

The influence of wire localisation for non-palpable breast lesions on visualisation of the sentinel node

Abstract: This study shows that guide wire localisation prior to the sentinel node procedure negatively influences visualisation of the sentinel node.

Cited by 10 publications

References 19 publications

Radio guided occult lesion localization (ROLL) for non‐palpable invasive breast cancer

Radio guided occult lesion localization (ROLL) for non‐palpable invasive breast cancer

Comparison of a 1-day and a 2-day protocol for lymphatic mapping and sentinel lymph node biopsy in patients with nonpalpable breast cancer

Anatomical Breast Imaging Derived Parameters Do Not Provide Incremental Information In Prediction of Nonvisualization of Sentinel Lymph Nodes On Lymphoscintigraphy

Contact Info

Product

Resources

About